Response to RAF/MEK/ERK Inhibitors in Patients with RAS-Altered and Wild-Type Tumors.

Authors

Mohamed A Gouda, Heather Lin, Lei Kang, Hung Le, Ecaterina E Dumbrava, Siqing Fu, Daniel D Karp, Apostolia Tsimberidou, Aung Naing, Sarina A Piha-Paul, Paula Pohlmann, Jordi Rodon, Timothy A Yap, Funda Meric-Bernstam, David S Hong

Published in

Journal of immunotherapy and precision oncology. Volume 9. Issue 4. Pages 147-152. Epub Sep 29, 2026.

PMID:
42820076
Bibliographic data and abstract were imported from PubMed on 02 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.